Dr. Christine Goertz: Pioneer in Clinical Research

You must be logged in to watch this video.

Biography

Christine Goertz, D.C., Ph.D. is a Professor in Musculoskeletal Research at the Duke Clinical Research Institute and Vice Chair for the Implementation of Spine Health Innovation in the Department of Orthopedic Surgery at Duke University. She is also the Chief Executive Officer of the Spine Institute for Quality and Adjunct Professor in the Department of Epidemiology, College of Public Health at the University of Iowa. Formerly she was Vice Chancellor of Research and Health Policy at Palmer College of Chiropractic for eleven years. Dr. Goertz received her Doctor of Chiropractic (D.C.) degree from Northwestern Health Sciences University in 1991 and her Ph.D. in Health Services Research, Policy and Administration from the School of Public Health at the University of Minnesota in 1999. Her 30-year research career has focused on working with multi-disciplinary teams to design and implement clinical and health services research studies designed to increase knowledge regarding the effectiveness and cost of complementary and integrative healthcare delivery. She has extensive experience in the administration of Federal grants, both as a PI and as a program official at the National Institutes of Health (NIH). Dr. Goertz has received nearly $44M in federal funding as either principal investigator or co-principal investigator, primarily from NIH and the Department of Defense, and has authored or co-authored over 130 peer-reviewed papers. Her primary area of focus is the investigation of patient-centered, non-pharmacological treatments for spine-related disorders. Dr. Goertz is a former member of the NIH/NCCIH National Advisory Council. She also served on the Board of Governors for the Patient Centered Outcomes Research Institute (PCORI), where she assumed numerous leadership roles, including her 3-year appointment in September 2019 as Chairperson of the PCORI Board of Governors by the Comptroller General of the United States.